NCT06860581

Brief Summary

Research on probiotic supplementation in the prevention and treatment of depressive and anxiety disorders and stress coping skills has been conducted for many years. This research project was designed to investigate the effects of both, probiotic supplementation and diet quality on a wide range of psychological, microbiological, biochemical, and clinical outcomes. The aim of the study was to assess the effects of targeted supplementation with Lactobacillus helveticus and Bifidobacterium longum on gut microbiota composition and quality, mental health, perceived stress intensity, psychosomatic response, and coping as well as body composition and bone density in young women who differed in diet quality. The study enrolled 120 healthy women in early adulthood (20-30 years of age) who were equally and randomly assigned to the intervention (Lh+Bl) or placebo (PLA) group. The intervention consisted of the administration of combined freeze-dried strains of Bifidobacterium longum Rosell®-175 and Lactobacillus helveticus Rosell®-52 (Lh+Bl) at dose of one capsule per day for 12 weeks. The total bacterial content per capsule was 3x109 CFU. At baseline, dietary habits were assessed using the KomPAN FFQ questionnaire and faecal samples were collected for gut microbiota analysis using Illumina next-generation sequencing technology. Anthropometric measurements were taken, and body composition and bone density were assessed using DEXA and displacement plethysmography using Bod Pod. Perceived stress and mental health were assessed using the psychological scales: PSS 10, Mini Cope, GHQ 28, and SOC-13. Salivary cortisol, DHEA and cortisol:DHEA ratio were measured as physiological markers of stress. After 12 weeks of supplementation, measurements were repeated and compared with baseline values.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for not_applicable healthy-volunteers

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2024

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
Last Updated

March 6, 2025

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

February 28, 2025

Last Update Submit

March 5, 2025

Conditions

Keywords

young adultssupplementationLactobacillus helveticusBifidobacterium longumstress markersbody compositionbone densitygut microbiotadiet

Outcome Measures

Primary Outcomes (3)

  • Microbiota composition

    Analysis of the gut microbiota will be performed in faecal samples in SANPROBI Research and Development Center laboratory in Szczecin using Illumina next-generation sequencing technology.

    At baseline, and the first to third day after the completion of the 12-week intervention.

  • Perceived stress intensity

    The PSS-10 (10-items Perceived Stress Scale) form was used to assess the intensity of stress related to one's own life experiences in the past month. Respondents reported on a 5-point Likert scale (0 = never, 1 = almost never, 2 = sometimes, 3 = quite often, 4 = very often) the extent to which situations in their lives during the past month were unpredictable, uncontrollable, and overwhelming. The scores for the four positively identified items (items 4, 5, 7, 8) are reversed. The maximum score is 40, with higher scores indicating higher levels of perceived stress. According to the instructions, scores in the range of 0-13 indicate a low level of stress, scores in the range of 14-26 indicate a moderate level of stress, and scores in the range of 27-40 indicate a high level of perceived stress.

    At baseline, and the first to third day after the completion of the 12-week intervention.

  • Stress-related neuroendocrine markers

    Included: salivary cortisol, salivary DHEA and salivary cortisol:DHEA ratio, faecal cortisol. Unstimulated saliva samples were collected from fasting participants in disposable Eppendorf plastic tubes using the spitting method for 10 minutes while the subjects rested. Prior to analysis, samples will be warmed and centrifuged at 1000 x g for 20 minutes to remove particulate material. Cortisol and DHEA in human saliva will be measured with commercially available kits using an immunoenzymatic method according to the manufacturer's instructions. All samples will be processed in duplicate during the same assay. Faecal samples for cortisol analysis will be warmed and diluted with water, and the subsequent procedure is the same as for saliva samples prepared for cortisol analysis, as described above.

    At baseline, and the first to third day after the completion of the 12-week intervention.

Secondary Outcomes (5)

  • Stress-coping strategies

    At baseline, and the first to third day after the completion of the 12-week intervention.

  • Psychosomatic symptoms

    At baseline, and the first to third day after the completion of the 12-week intervention.

  • Sense of coherence

    At baseline, and the first to third day after the completion of the 12-week intervention.

  • Body composition

    At baseline, and the first to third day after the completion of the 12-week intervention..

  • Bone density

    At baseline, and the first to third day after the completion of the 12-week intervention. .

Other Outcomes (3)

  • Diet and lifestyle

    At baseline of the intervention.

  • Socioeconomic status (SES)

    At baseline of the intervention.

  • Personality dimensions

    At baseline of the intervention.

Study Arms (2)

Probiotic bacteria

EXPERIMENTAL

Bifidobacterium longum and Lactobacillus helveticus (Lh+Bl)

Dietary Supplement: Intervention (Sanprobi®Stress)

Placebo

PLACEBO COMPARATOR

Capsules containing only bulking agents (PLA).

Other: Placebo

Interventions

The composition of lyophilized strains of Bifidobacterium longum Rosell®-175 and Lactobacillus helveticus Rosell®-52 (trade name: Sanprobi®Stress; manufacturer: Sanprobi sp. z o.o. sp. k., Szczecin, Poland) was placed in capsules, the shell of which consisted of hydroxypropylmethylcellulose. The total bacterial content per capsule was 3x109 CFU. Filling substances were potato starch and magnesium stearate. The weight of the capsule was 420 mg. Dosage: 1 capsule/day for 12 weeks.

Also known as: Lh+Bl
Probiotic bacteria
PlaceboOTHER

Filling substances were only potato starch and magnesium stearate.

Also known as: PLA
Placebo

Eligibility Criteria

Age20 Years - 30 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly biological women are eligibilitible.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • female sex,
  • age 20-30 years,
  • BMI \< 30 kg/m2

You may not qualify if:

  • diagnosed chronic and/or serious health disorders (e.g. diabetes, asthma, hypertension, renal diseases),
  • pregnancy,
  • taking any probiotics for 8 weeks prior to enrollment to the study protocol, -
  • recent and current antibiotic treatment, ore use of pharmaceutical antidepressant treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Poznan University of Life Sciences, Department of Human Nutrition and Dietetics

Poznan, Greater Poland Voivodeship, 60-461, Poland

Location

Related Publications (31)

  • Wu SI, Wu CC, Tsai PJ, Cheng LH, Hsu CC, Shan IK, Chan PY, Lin TW, Ko CJ, Chen WL, Tsai YC. Psychobiotic Supplementation of PS128TM Improves Stress, Anxiety, and Insomnia in Highly Stressed Information Technology Specialists: A Pilot Study. Front Nutr. 2021 Mar 26;8:614105. doi: 10.3389/fnut.2021.614105. eCollection 2021.

    PMID: 33842519BACKGROUND
  • Wu GD, Compher C, Chen EZ, Smith SA, Shah RD, Bittinger K, Chehoud C, Albenberg LG, Nessel L, Gilroy E, Star J, Weljie AM, Flint HJ, Metz DC, Bennett MJ, Li H, Bushman FD, Lewis JD. Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. Gut. 2016 Jan;65(1):63-72. doi: 10.1136/gutjnl-2014-308209. Epub 2014 Nov 26.

    PMID: 25431456BACKGROUND
  • Tiollier E, Chennaoui M, Gomez-Merino D, Drogou C, Filaire E, Guezennec CY. Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med. 2007 Sep;172(9):1006-11. doi: 10.7205/milmed.172.9.1006.

    PMID: 17937368BACKGROUND
  • Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015 Aug;48:258-64. doi: 10.1016/j.bbi.2015.04.003. Epub 2015 Apr 7.

    PMID: 25862297BACKGROUND
  • Sanborn V, Azcarate-Peril MA, Updegraff J, Manderino LM, Gunstad J. A randomized clinical trial examining the impact of LGG probiotic supplementation on psychological status in middle-aged and older adults. Contemp Clin Trials Commun. 2018 Nov 14;12:192-197. doi: 10.1016/j.conctc.2018.11.006. eCollection 2018 Dec.

    PMID: 30511028BACKGROUND
  • Rudzki L, Ostrowska L, Pawlak D, Malus A, Pawlak K, Waszkiewicz N, Szulc A. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study. Psychoneuroendocrinology. 2019 Feb;100:213-222. doi: 10.1016/j.psyneuen.2018.10.010. Epub 2018 Oct 16.

    PMID: 30388595BACKGROUND
  • Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Cooper C, Dawson-Hughes B, El-Hajj Fuleihan G, Leslie WD, Lewiecki EM, Luckey MM, McCloskey EV, Papapoulos SE, Poiana C, Rizzoli R; FRAX((R)) Position Development Conference Members. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX((R)). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX(R) in clinical practice. J Clin Densitom. 2011 Jul-Sep;14(3):171-80. doi: 10.1016/j.jocd.2011.05.007.

    PMID: 21810521BACKGROUND
  • Nilsson AG, Sundh D, Backhed F, Lorentzon M. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial. J Intern Med. 2018 Sep;284(3):307-317. doi: 10.1111/joim.12805. Epub 2018 Jul 22.

    PMID: 29926979BACKGROUND
  • Lindstrom B, Eriksson M. Contextualizing salutogenesis and Antonovsky in public health development. Health Promot Int. 2006 Sep;21(3):238-44. doi: 10.1093/heapro/dal016. Epub 2006 May 22.

    PMID: 16717056BACKGROUND
  • Lee YH, Kim YY, Chang JY, Kho HS. Changes in oral mucosal MUC1 expression and salivary hormones throughout the menstrual cycle. Oral Dis. 2015 Nov;21(8):962-8. doi: 10.1111/odi.12367. Epub 2015 Sep 23.

    PMID: 26332504BACKGROUND
  • Lee EH. Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res (Korean Soc Nurs Sci). 2012 Dec;6(4):121-7. doi: 10.1016/j.anr.2012.08.004. Epub 2012 Sep 18.

    PMID: 25031113BACKGROUND
  • Lalitsuradej E, Sirilun S, Sittiprapaporn P, Sivamaruthi BS, Pintha K, Tantipaiboonwong P, Khongtan S, Fukngoen P, Peerajan S, Chaiyasut C. The Effects of Synbiotics Administration on Stress-Related Parameters in Thai Subjects-A Preliminary Study. Foods. 2022 Mar 6;11(5):759. doi: 10.3390/foods11050759.

    PMID: 35267392BACKGROUND
  • Kowalkowska J, Wadolowska L, Hamulka J, Wojtas N, Czlapka-Matyasik M, Kozirok W, Bronkowska M, Sadowska J, Naliwajko S, Dziaduch I, Koronowicz A, Piasna-Slupecka E, Czeczelewska E, Czeczelewski J, Kostecka M, Dlugosz A, Loboda D, Jeruszka-Bielak M. Reproducibility of a Short-Form, Multicomponent Dietary Questionnaire to Assess Food Frequency Consumption, Nutrition Knowledge, and Lifestyle (SF-FFQ4PolishChildren) in Polish Children and Adolescents. Nutrients. 2019 Dec 3;11(12):2929. doi: 10.3390/nu11122929.

    PMID: 31816859BACKGROUND
  • Kowalkowska J, Wadolowska L, Czarnocinska J, Galinski G, Dlugosz A, Loboda D, Czlapka-Matyasik M. Data-Driven Dietary Patterns and Diet Quality Scores: Reproducibility and Consistency in Sex and Age Subgroups of Poles Aged 15-65 Years. Nutrients. 2020 Nov 24;12(12):3598. doi: 10.3390/nu12123598.

    PMID: 33255188BACKGROUND
  • Kowalkowska J, Wadolowska L, Czarnocinska J, Czlapka-Matyasik M, Galinski G, Jezewska-Zychowicz M, Bronkowska M, Dlugosz A, Loboda D, Wyka J. Reproducibility of a Questionnaire for Dietary Habits, Lifestyle and Nutrition Knowledge Assessment (KomPAN) in Polish Adolescents and Adults. Nutrients. 2018 Dec 1;10(12):1845. doi: 10.3390/nu10121845.

    PMID: 30513711BACKGROUND
  • Kim CS, Cha L, Sim M, Jung S, Chun WY, Baik HW, Shin DM. Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. J Gerontol A Biol Sci Med Sci. 2021 Jan 1;76(1):32-40. doi: 10.1093/gerona/glaa090.

    PMID: 32300799BACKGROUND
  • Karakula-Juchnowicz H, Rog J, Juchnowicz D, Loniewski I, Skonieczna-Zydecka K, Krukow P, Futyma-Jedrzejewska M, Kaczmarczyk M. The study evaluating the effect of probiotic supplementation on the mental status, inflammation, and intestinal barrier in major depressive disorder patients using gluten-free or gluten-containing diet (SANGUT study): a 12-week, randomized, double-blind, and placebo-controlled clinical study protocol. Nutr J. 2019 Aug 31;18(1):50. doi: 10.1186/s12937-019-0475-x.

    PMID: 31472678BACKGROUND
  • Jansson PA, Curiac D, Lazou Ahren I, Hansson F, Martinsson Niskanen T, Sjogren K, Ohlsson C. Probiotic treatment using a mix of three Lactobacillus strains for lumbar spine bone loss in postmenopausal women: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatol. 2019 Nov;1(3):e154-e162. doi: 10.1016/S2665-9913(19)30068-2. Epub 2019 Oct 23.

    PMID: 38229392BACKGROUND
  • Harvey NC, Gluer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C, Kendler D, Lamy O, Laslop A, Camargos BM, Reginster JY, Rizzoli R, Kanis JA. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015 Sep;78:216-24. doi: 10.1016/j.bone.2015.05.016. Epub 2015 May 16.

    PMID: 25988660BACKGROUND
  • Harahap IA, Suliburska J. Probiotics and Isoflavones as a Promising Therapeutic for Calcium Status and Bone Health: A Narrative Review. Foods. 2021 Nov 3;10(11):2685. doi: 10.3390/foods10112685.

    PMID: 34828966BACKGROUND
  • Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979 Feb;9(1):139-45. doi: 10.1017/s0033291700021644.

    PMID: 424481BACKGROUND
  • Czlapka-Matyasik M, Lonnie M, Wadolowska L, Frelich A. "Cutting Down on Sugar" by Non-Dieting Young Women: An Impact on Diet Quality on Weekdays and the Weekend. Nutrients. 2018 Oct 9;10(10):1463. doi: 10.3390/nu10101463.

    PMID: 30304771BACKGROUND
  • Dutheil F, de Saint Vincent S, Pereira B, Schmidt J, Moustafa F, Charkhabi M, Bouillon-Minois JB, Clinchamps M. DHEA as a Biomarker of Stress: A Systematic Review and Meta-Analysis. Front Psychiatry. 2021 Jul 6;12:688367. doi: 10.3389/fpsyt.2021.688367. eCollection 2021.

    PMID: 34295276BACKGROUND
  • Goldberg D.P. General Health Questionnaire (GHQ) - The Detection of Psychiatric Illness by Questionnaire: A Technique for the Identification and Assessment of Nonpsychotic Psychiatric Illness; Oxford University Press: London, 1972.

    BACKGROUND
  • Chaiyasut C, Sivamaruthi BS, Kesika P, Khongtan S, Khampithum N, Thangaleela S, Peerajan S, Bumrungpert A, Chaiyasut K, Sirilun S, Sittiprapaporn P. Synbiotic Supplementation Improves Obesity Index and Metabolic Biomarkers in Thai Obese Adults: A Randomized Clinical Trial. Foods. 2021 Jul 7;10(7):1580. doi: 10.3390/foods10071580.

    PMID: 34359450BACKGROUND
  • Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989 Feb;56(2):267-83. doi: 10.1037//0022-3514.56.2.267.

    PMID: 2926629BACKGROUND
  • Bykowska-Derda A, Czlapka-Matyasik M, Kaluzna M, Ruchala M, Ziemnicka K. Diet quality scores in relation to fatness and nutritional knowledge in women with polycystic ovary syndrome: case-control study. Public Health Nutr. 2021 Aug;24(11):3389-3398. doi: 10.1017/S1368980020001755. Epub 2020 Jul 21.

    PMID: 32693854BACKGROUND
  • Abdul Rahman H, Bani Issa W, Naing L. Psychometric properties of brief-COPE inventory among nurses. BMC Nurs. 2021 May 6;20(1):73. doi: 10.1186/s12912-021-00592-5.

    PMID: 33952254BACKGROUND
  • Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.

    PMID: 16250744BACKGROUND
  • Antonovsky A. Unraveling the Mystery of Health: How People Manage Stress and Stay Well; Jossey-Bass: San Francisco, 1987

    BACKGROUND
  • Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med. 1993 Mar;36(6):725-33. doi: 10.1016/0277-9536(93)90033-z.

    PMID: 8480217BACKGROUND

MeSH Terms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Boguslaw Stelcer, PhD

    Poznan University of Life Sciences

    STUDY CHAIR
  • Magdalena Czlapka-Matyasik, PhD

    Poznan University of Life Sciences

    PRINCIPAL INVESTIGATOR
  • Malgorzata Wozniewicz, PhD

    Poznan University of Life Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Neither the researchers nor the participants knew whether intervention or placebo was administered. The preparations were administrated to each participant in envelopes marked with a unique code. The supplements were in the same capsules as the plecebo and could not be distinguished by appearance and taste. Assignment of study material (A - placebo or B - intervention) to individuals was randomised by computer-generated codes, using Research Randomizer (www.randomizer.org), obtained from the supplement manufacturer. The study was decoded after results collection was completed.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Experimental dubleblinded study with interventional and placebo equal goups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2025

First Posted

March 6, 2025

Study Start

September 26, 2023

Primary Completion

December 12, 2023

Study Completion

March 18, 2024

Last Updated

March 6, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations